Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

已完结 10 由 xiaolaji100 发布于 2026/4/9 14:06:41

DOI:10.1136/gutjnl-2025-337431
作者：Xiao-Dong Zhou,?Qiong-Yue Fan,?Christopher D Byrne,?Giovanni Targher,?Mark D Muthiah,?Daniel Q Huang,?Qin-Fen Chen,?Mazen Noureddin,?Wenhao Li,?Vlad Ratziu,?Rohit Loomba,?Sven M Francque,?Arun J Sanya
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1136/gutjnl-2025-337431

BMJ

Abstract：Metabolic dysfunction-associated steatohepatitis (MASH) is a multifactorial metabolic liver disease that occurs in the context of obesity, insulin resistance and cardiometabolic comorbiditie

应助信息

1天前

Book学术机器人

51ede424f12511f097d734735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/4/9 14:06:41 Book学术AI机器人已找到文献并上传

2026/4/9 14:06:41 Book学术AI机器人收到请求，开始寻找文献

2026/4/9 14:06:41 已向机器人发送请求

1天前

xiaolaji100 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:IOPscienceNonthermal plasma synthesis of silicon nanoparticles and their thermal transport properties